Survey: Surveillance Patients Show Strong Interest in Non-Invasive Test Options
12th June 2024
In December 2023, using the Bladder Cancer Advocacy Network’s (BCAN’s) Patient Survey Network, we surveyed 1,507 US patients being monitored for non-muscle invasive bladder cancer (NMIBC). Those surveyed displayed a strong interest in non-invasive test options. Read More
Cxbladder Bulletin - May 2024
31st May 2024
Clinical Utility of Cxbladder to Headline at AUA 2024
30th April 2024
A ground-breaking study demonstrating the clinical utility of Cxbladder is to be the centrepiece of Pacific Edge’s activities at the 2024 American Urological Association (AUA) Annual Meeting to be held May 3 – 6 in San Antonio, Texas. Read More